Thermo Fisher Scientific OCI Foreign Currency Translation Gain (Loss), Tax increased by 113.0% to $27.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 113.0%, from -$207.00M to $27.00M.
Changes reflect the tax-related volatility of international operations due to currency market movements rather than operational performance.
This metric captures the tax impact associated with gains or losses arising from the translation of financial statements...
Commonly reported by multinational corporations with significant foreign currency exposure.
ms_oci_foreign_currency_translation_tax| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$23.00M | $74.00M | $89.00M | $173.00M | $157.00M | -$36.00M | $0.00 | $71.00M | $166.00M | $88.00M | -$244.00M | -$207.00M | $27.00M |
| QoQ Change | — | +421.7% | +20.3% | +94.4% | -9.2% | -122.9% | +100.0% | — | +133.8% | -47.0% | -377.3% | +15.2% | +113.0% |
| YoY Change | — | — | — | +852.2% | +112.2% | -140.4% | -100.0% | -54.8% | +561.1% | — | -443.7% | -224.7% | +113.0% |